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ABSTRACT
Esophageal malignancy encompasses a group of diseases that are mostly represented by the squamous cell carcinoma 
and the adenocarcinoma. Quite frequently, these neoplasms present aggressive behavior; therefore, the diagnosis is 
often made when the condition is in advanced stages. Dysphagia is the typical clinical complaint, although it is present 
only when most of the lumen is obstructed. Therefore, quite often, the metastatic disease is first diagnosed, which 
contributes to the patient’s poor survival expectancy. The authors report the case of a 58-year-old man who looked for 
medical care complaining of a long-term history of scapular pain. The diagnostic work-up disclosed a cervical spine lytic 
lesion surrounded by a tumoral mass shown by computed tomography. The cervical tumor was sampled by fine needle 
aspiration, revealing an undifferentiated carcinoma. The outcome was unfavorable and the patient died. The autopsy 
findings revealed metastatic disease to the spine and central nervous system, and the primary tumor was found to be 
an esophageal squamous cell carcinoma, which had progressed without typical dysphagia.
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CASE REPORT
A 58-year-old Caucasian man, born in a southern 
state of Brazil, sought the medical facility complaining 
of a 3-month history of continuous right shoulder 
burning pain (precisely in the scapular region). This 
symptom irradiated from the cervical spine hampering 
the movements of his right arm and was alleviated with 
the flexion of the neck to the right position. He referred 
8 kg of weight loss during this period, but denied 
inappetence, dysphagia, other dyspeptic symptoms or 
change in intestinal habits. He was a pottery worker for 
25 years, was used to drinking daily 250 g of alcohol 
for 5 years and smoking 40 packs/year of tobacco.
The cervical spine radiography disclosed a lytic 
lesion in the vertebral body of C6 characterized as a ghost 
vertebra, consistent with bone metastasis (Figure 1A). 
The patient was hospitalized for investigation and pain 
control. The cervical spine computed tomography (CT) 
depicted a tumor mass (Figure 1B and 1C), which 
cytological examination of the fine needle aspirate 
was consistent with an undifferentiated carcinoma 
(Figure 2).
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During hospitalization, the patient presented 
mental confusion, psychomotor agitation, and 
drowsiness, followed by loss of muscular strength 
in the right superior limb. The brain CT revealed the 
presence of a left parietal nodular lesion (Figure 1D). 
Neurological and clinical status worsened; therefore, 
palliative care was instituted and the investigation for 
malignancy of unknown primary site was discontinued. 
Immunohistochemical analysis of the aspirate could 
not be performed. The patient died soon after 
hospitalization and an autopsy was performed.
AUTOPSY FINDINGS
An ulcerated and vegetating lesion, measuring 
3.0 × 1.5 cm was found in the distal third of the 
esophagus (Figure 3A), which, on histology, was 
represented by an epidermoid carcinoma with 
Figure 1. A – Lateral cervical spine radiography showing lytic lesion in C6 (arrow); B – Cervical computed tomography 
(CT) (bone window) showing vertebral body and left pedicle lytic lesion; C – Cervical CT (soft tissue window) 
showing the tumoral mass with heterogeneous contrast enhancement; D – Parietal nodular lesion that shows 
contrast enhancement, consistent with metastasis.
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poorly-differentiated and well-differentiated areas 
with basaloid transformation (Figure 3B). Metastasis 
to the left brain hemisphere (Figure 4A and 4B) was 
found. Thoracic and cervical spine vertebrae were 
enlarged by tumoral infiltration of the bone and soft 
tissue. Additional findings included liver metastasis and 
neoplastic cells filling the pulmonary vessels.
DISCUSSION
Esophageal carcinoma (EC) is the eighth most 
common type of cancer. In 2008, 481,000 new 
cases per year were registered accompanied by 
406,000 deaths, worldwide, in the same period 
representing the sixth cause of death due to neoplasia.1 
This neoplasm predominantly affects men (male:female 
ratio of 5.84:1) with a mean age of 61.6 years; whereas 
women show a mean age of 72.9 years at the time 
of diagnosis.2
The diagnosis of EC is frequently challenging 
since the typical symptom, represented by dysphagia, 
occurs only when two-thirds of the visceral lumen is 
involved.3,4 Therefore, the diagnosis is predominantly 
done in the advanced stages (stages III and IV),3 which 
Figure 2. Photomicrography of the fine needle aspiration 
cytology showing the presence of non-differentiated 
malignancy (H&E, 400X).
Figure 3. A – Gross view of the ulcerovegetating lesion on the esophageal distal third, measuring 3 × 1.5 cm; 
B – Photomicrography of the ulcerated esophageal lesion showing the presence of epidermoid carcinoma (H&E, 40X).
Figure 4. A – Gross view of the brain showing the presence of a cortical nodular lesion (arrow); B – Photomicrography 
of the transition between the nervous parenchyma and the neoplastic infiltration (H&E, 40X).
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justifies the poor prognosis, represented by the 
five-year survival rate of less than 10% in Western 
countries.5
EC is a neoplasia that has a high lethality. The 
number of deaths per year is very similar to the number 
of new cases.6 Survival after the diagnosis ranges from 
3 to 6 months.7
According to the Brazilian National Institute of 
Cancer (INCA-Brazil), genetic and environmental 
factors are involved with the development of EC. 
Around 80% of EC are related to tobacco smoking, 
alcoholism, and alimentary habits.1,3,4
Sons and Borchard,2 in their study comprising 
171 cases of EC, found 91.8% of cases of epidermoid 
carcinoma, 6.4% of adenocarcinoma, and 1.8% of 
other types. Epidermoid carcinoma, derived from the 
non-keratinized stratified epithelium, occurs mainly 
after prolonged tobacco exposure, arises in the middle 
and distal third of the esophagus, and characteristically 
involves men over 50 years.8,9 Adenocarcinoma 
frequently involves the distal third of the esophagus, 
occurs more frequently among obese patients, and is 
related to gastroesophageal reflux disease.8,9
EC presents fast growth, which is evidenced 
by 50% of the new cases showing non-resectable 
metastases at the time of diagnosis.10 Metastatic 
dissemination may occur through the lymphatic 
system, the blood stream, or by contiguity. The main 
metastatic sites are: abdominal lymph nodes (45%) 
cervical and supraclavicular lymph nodes (3–37%), 
liver (23–47%), lungs (22–52%), bones (45–14%), 
and central nervous system (1–5%).11,12
The case reported herein is in accordance with 
the literature with respect to the histologic type and 
the risk factors; namely, age, gender, origin,13 lifestyle, 
and alimentary habits, besides the history of alcoholism 
and tobacco smoking.3,14
Dysphagia and odynophagia, or any retrosternal 
discomfort, are fundamental diagnostic clues.4,15 In our 
case, the lack of such symptoms was responsible for the 
misdiagnosis, and was the reason for not performing 
an upper digestive endoscopy. The lack of esophageal 
symptoms was explained by the non-stenotic pattern 
of the lesion.
The right shoulder pain, which presented the 
patient’s complaint, was due to the cervical spine 
metastasis. Esophageal epidermoid carcinoma bone 
metastases most commonly occur in the lumbar spine 
followed by the involvement of the thoracic and 
cervical regions. Compressive symptoms are more 
frequently found in the thoracic area of the spine, 
followed by the cervical (10–30%) and sacral/lumbar 
(20–30%), probably because of the narrow diameter 
of the spinal canal.16
In 1982, 1984, and 1986, three different 
researchers reported autopsy studies on esophageal 
cancer.2,17,18 In these series, which comprised 79, 171, 
and 231 cases, respectively, no bone metastases were 
found. However, Siame et al.7 reported three cases of 
esophageal epidermoid carcinoma with no esophageal 
symptoms, which presented bone metastases to the 
femur and vertebrae.
In the case reported herein, the mental status and 
neurological signs, as well as the tomographic findings, 
were concordant with the autopsy findings. Liver and 
pulmonary metastases are also in accordance with the 
literature.11,12,17
As aforementioned, EC is frequently asymptomatic, 
which, in this case, was responsible for the lack of 
clinical investigation. Therefore, once again, the 
autopsy shows undeniable value for medical assistance 
and teaching purposes, besides the demonstration of 
the rare metastatic site of EC.
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